Genetic Technologies Limited advised that Mr. Tony Di Pietro has provided his notice of resignation as Chief Financial Officer (CFO) of the Company. The Company has commenced a search for a new CFO with requisite dual ASX and Nasdaq listed company expertise. Mr. Di Pietro will remain in the role of CFO until a replacement commences with GTG or the end of March 2024, whichever date is the earliest.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.05 AUD | -1.96% |
|
-26.47% | -62.96% |
Jul. 16 | Genetic Technologies Names CFO | MT |
Jul. 16 | Genetic Technologies Limited Appoints Mark Ziirsen as Chief Financial Officer | CI |
1st Jan change | Capi. | |
---|---|---|
-62.96% | 4.54M | |
+19.32% | 84.59B | |
-21.99% | 77.33B | |
+2.32% | 27.12B | |
-5.06% | 18.19B | |
+6.95% | 18.49B | |
+7.69% | 16.49B | |
+76.20% | 13.55B | |
+76.56% | 13.03B | |
-27.89% | 12.43B |
- Stock Market
- Equities
- GTG Stock
- News Genetic Technologies Limited
- Genetic Technologies Limited Announces Resignation of Tony Di Pietro as Chief Financial Officer